Meritocrat
GLP-1 Apprentice
The monopolizing, future big Pharma trillionaire tyrant, Lilly just pulled the plug on a trial running bimagrumab. The trial was originally set to end in late 2026 and it was started by small firm, Versanis bio, a startup. Lilly bought versanis two years ago and now ended the trial. Bimagrumab had already shown incredible results with reducing muscle loss to under 10% during long-term fat loss. When it was used alongside a GLP-1 drug, not only did weight loss increase, but so did lean mass.
"The study stoppage comes as the FDA appears to be indicating that drugs like bimagrumab may need to do more than just improve muscle composition.."
Crony capitalism aka plutocracy aka oligarchy at work. Clearly, the plebes aren't meant to enjoy the fruits designed for the Patricians.
Another firm halted testing of their myostatin inhibtor with GLP's. "Veru earlier this week said the agency “now guides that incremental weight loss” over a GLP-1 drug alone “is an acceptable primary endpoint to support approval.” Veru’s shares fell 3% on Tuesday following that announcement, and another 3% Thursday."
It's an actual trend with many other pharmaceutical firms doing the same thing.
https://www.biopharmadive.com/news/lilly-terminate-obesity-trial-bimagrumab-muscle-diabetes/761105/
"The study stoppage comes as the FDA appears to be indicating that drugs like bimagrumab may need to do more than just improve muscle composition.."
Crony capitalism aka plutocracy aka oligarchy at work. Clearly, the plebes aren't meant to enjoy the fruits designed for the Patricians.
Another firm halted testing of their myostatin inhibtor with GLP's. "Veru earlier this week said the agency “now guides that incremental weight loss” over a GLP-1 drug alone “is an acceptable primary endpoint to support approval.” Veru’s shares fell 3% on Tuesday following that announcement, and another 3% Thursday."
It's an actual trend with many other pharmaceutical firms doing the same thing.
https://www.biopharmadive.com/news/lilly-terminate-obesity-trial-bimagrumab-muscle-diabetes/761105/
